Found: 127
Select item for more details and to access through your institution.
Economic Considerations in the Use of Novel Targeted Therapies for Lung Cancer: Review of Current Literature.
- Published in:
- 2017
- By:
- Publication type:
- journal article
How affordable are targeted therapies in non-small cell lung cancer?
- Published in:
- 2011
- By:
- Publication type:
- journal article
Repeat Next-Generation Sequencing (15-Gene Panel) in Unifocal, Synchronous, and Metachronous Non-Small-Cell Lung Cancer—A Single-Center Experience.
- Published in:
- Current Oncology, 2024, v. 31, n. 8, p. 4476, doi. 10.3390/curroncol31080334
- By:
- Publication type:
- Article
Can a computerized format replace a paper form in PRO and HRQL evaluation? Psychometric testing of the computer-assisted LCSS instrument (eLCSS-QL).
- Published in:
- Supportive Care in Cancer, 2013, v. 21, n. 1, p. 165, doi. 10.1007/s00520-012-1507-7
- By:
- Publication type:
- Article
Enhancing decision making about participation in cancer clinical trials: development of a question prompt list.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Determinants of quality of life in patients with advanced cancer.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Development and evaluation of a decision aid for patients considering first-line chemotherapy for metastatic breast cancer.
- Published in:
- Health Expectations, 2008, v. 11, n. 1, p. 35, doi. 10.1111/j.1369-7625.2007.00470.x
- By:
- Publication type:
- Article
Editorial: Update on the Biology, Management, and Treatment of Small Cell Lung Cancer.
- Published in:
- 2020
- By:
- Publication type:
- Editorial
Minimization of resource utilization data collected within cost-effectiveness analyses conducted alongside Canadian Cancer Trials Group phase III trials.
- Published in:
- Clinical Trials, 2021, v. 18, n. 4, p. 500, doi. 10.1177/17407745211005045
- By:
- Publication type:
- Article
Economic Analysis: Randomized Placebo-Controlled Clinical Trial of Erlotinib in Advanced Non–Small Cell Lung Cancer.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2010, v. 102, n. 5, p. 298, doi. 10.1093/jnci/djp518
- By:
- Publication type:
- Article
Factors associated with cognitive impairment and cognitive concerns in patients with metastatic non-small cell lung cancer.
- Published in:
- Neuro-Oncology Practice, 2022, v. 9, n. 1, p. 50, doi. 10.1093/nop/npab056
- By:
- Publication type:
- Article
Analysis of Adjuvant Chemotherapy in Non-Small Cell Lung Cancer.
- Published in:
- European Journal of Clinical & Medical Oncology, 2010, v. 2, n. 2, p. 37
- By:
- Publication type:
- Article
Pathological Subtyping and Molecular Profiling in Non-small Cell Lung Cancer: A Clinician's Perspective.
- Published in:
- Canadian Journal of Pathology, 2014, p. 158
- By:
- Publication type:
- Article
The economic value of liquid biopsy for genomic profiling in advanced non-small cell lung cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221112696
- By:
- Publication type:
- Article
The dawn of a new era, adjuvant EGFR inhibition in resected non-small cell lung cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211056306
- By:
- Publication type:
- Article
Real-World Outcomes of Patients with Advanced Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer in Canada Using Data Extracted by Large Language Model-Based Artificial Intelligence.
- Published in:
- Current Oncology, 2024, v. 31, n. 4, p. 1947, doi. 10.3390/curroncol31040146
- By:
- Publication type:
- Article
Canadian Consensus Recommendations for the Management of Operable Stage II/III Non-Small-Cell Lung Cancer: Results of a Modified Delphi Process.
- Published in:
- Current Oncology, 2023, v. 30, n. 12, p. 10363, doi. 10.3390/curroncol30120755
- By:
- Publication type:
- Article
Canadian Consensus Recommendations on the Management of KRAS G12C-Mutated NSCLC.
- Published in:
- Current Oncology, 2023, v. 30, n. 7, p. 6473, doi. 10.3390/curroncol30070476
- By:
- Publication type:
- Article
Canadian Consensus Recommendations on the Management of Extensive-Stage Small-Cell Lung Cancer.
- Published in:
- Current Oncology, 2023, v. 30, n. 7, p. 6289, doi. 10.3390/curroncol30070465
- By:
- Publication type:
- Article
Tobacco Use and Response to Immune Checkpoint Inhibitor Therapy in Non-Small Cell Lung Cancer.
- Published in:
- Current Oncology, 2022, v. 29, n. 9, p. 6260, doi. 10.3390/curroncol29090492
- By:
- Publication type:
- Article
Consensus Recommendations to Optimize Testing for New Targetable Alterations in Non-Small Cell Lung Cancer.
- Published in:
- Current Oncology, 2022, v. 29, n. 7, p. 4981, doi. 10.3390/curroncol29070396
- By:
- Publication type:
- Article
Health and Budget Impact of Liquid-Biopsy-Based Comprehensive Genomic Profile (CGP) Testing in Tissue-Limited Advanced Non-Small Cell Lung Cancer (aNSCLC) Patients.
- Published in:
- Current Oncology, 2021, v. 28, n. 6, p. 5278, doi. 10.3390/curroncol28060441
- By:
- Publication type:
- Article
Canadian Consensus Recommendations on the Management of MET-Altered NSCLC.
- Published in:
- Current Oncology, 2021, v. 28, n. 6, p. 4552, doi. 10.3390/curroncol28060386
- By:
- Publication type:
- Article
Reflex ROS1 IHC Screening with FISH Confirmation for Advanced Non-Small Cell Lung Cancer—A Cost-Efficient Strategy in a Public Healthcare System.
- Published in:
- Current Oncology, 2021, v. 28, n. 5, p. 3268, doi. 10.3390/curroncol28050284
- By:
- Publication type:
- Article
Recommendations for reporting tissue and circulating tumour (ct)DNA next-generation sequencing results in non-small cell lung cancer.
- Published in:
- British Journal of Cancer, 2024, v. 131, n. 2, p. 212, doi. 10.1038/s41416-024-02709-4
- By:
- Publication type:
- Article
Integrating circulating-free DNA (cfDNA) analysis into clinical practice: opportunities and challenges.
- Published in:
- 2022
- By:
- Publication type:
- journal article
The impact of multidisciplinary cancer conferences on overall survival: a meta-analysis.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 3, p. 356, doi. 10.1093/jnci/djad268
- By:
- Publication type:
- Article
Early mortality in patients with cancer treated with immune checkpoint inhibitors in routine practice.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2023, v. 115, n. 8, p. 949, doi. 10.1093/jnci/djad090
- By:
- Publication type:
- Article
The impact of symptoms and comorbidity on health utility scores and health-related quality of life in small cell lung cancer using real world data.
- Published in:
- Quality of Life Research, 2021, v. 30, n. 2, p. 445, doi. 10.1007/s11136-020-02615-1
- By:
- Publication type:
- Article
Satisfaction with oncology care among patients with advanced cancer and their caregivers.
- Published in:
- Quality of Life Research, 2013, v. 22, n. 9, p. 2341, doi. 10.1007/s11136-013-0371-3
- By:
- Publication type:
- Article
Screening for lung cancer with computed tomography: protocol for systematic reviews for the Canadian Task Force on Preventive Health Care.
- Published in:
- Systematic Reviews, 2024, v. 13, n. 1, p. 1, doi. 10.1186/s13643-024-02506-3
- By:
- Publication type:
- Article
Promising targets and current clinical trials in metastatic non-squamous NSCLC.
- Published in:
- Frontiers in Oncology, 2014, v. 4, p. 1, doi. 10.3389/fonc.2014.00329
- By:
- Publication type:
- Article
Economic impact of tissue testing and treatments of metastatic NSCLC in the era of personalized medicine.
- Published in:
- Frontiers in Oncology, 2014, v. 4, p. 1, doi. 10.3389/fonc.2014.00258
- By:
- Publication type:
- Article
Biomarkers that currently effect clinical practice in lung cancer: EGFR, ALK, MET, ROS-1 and KRAS.
- Published in:
- Frontiers in Oncology, 2014, v. 4, p. 1, doi. 10.3389/fonc.2014.00204
- By:
- Publication type:
- Article
Ancillary Testing in Lung Cancer Diagnosis.
- Published in:
- Pulmonary Medicine, 2012, p. 1, doi. 10.1155/2012/249082
- By:
- Publication type:
- Article
Association of two BRM promoter polymorphisms and smoking status with malignant pleural mesothelioma risk and prognosis.
- Published in:
- Molecular Carcinogenesis, 2019, v. 58, n. 11, p. 1960, doi. 10.1002/mc.23088
- By:
- Publication type:
- Article
The Use of Wearable Devices in Oncology Patients: A Systematic Review.
- Published in:
- Oncologist, 2024, v. 29, n. 4, p. e419, doi. 10.1093/oncolo/oyad305
- By:
- Publication type:
- Article
Utilization of Immunotherapy in Patients with Cancer Treated in Routine Care Settings: A Population-Based Study Using Health Administrative Data.
- Published in:
- Oncologist, 2022, v. 27, n. 8, p. 675, doi. 10.1093/oncolo/oyac085
- By:
- Publication type:
- Article
Can Oncologists Predict the Efficacy of Treatments in Randomized Trials?
- Published in:
- Oncologist, 2021, v. 26, n. 1, p. 56, doi. 10.1634/theoncologist.2020-0054
- By:
- Publication type:
- Article
Prolonging Survival: The Role of Immune Checkpoint Inhibitors in the Treatment of Extensive‐Stage Small Cell Lung Cancer.
- Published in:
- Oncologist, 2020, v. 25, n. 11, p. 981, doi. 10.1634/theoncologist.2020-0193
- By:
- Publication type:
- Article
Amplifying Outcomes: Checkpoint Inhibitor Combinations in First‐Line Non‐Small Cell Lung Cancer.
- Published in:
- Oncologist, 2020, v. 25, n. 1, p. 64, doi. 10.1634/theoncologist.2019-0027
- By:
- Publication type:
- Article
The Impact of Brain Metastases and Associated Neurocognitive Aspects on Health Utility Scores in EGFR Mutated and ALK Rearranged NSCLC: A Real World Evidence Analysis.
- Published in:
- Oncologist, 2019, v. 24, n. 7, p. e501, doi. 10.1634/theoncologist.2018-0544
- By:
- Publication type:
- Article
Systemic Therapy Use and Outcomes After Relapse from Preoperative Radiation and Extrapleural Pneumonectomy for Malignant Pleural Mesothelioma.
- Published in:
- Oncologist, 2019, v. 24, n. 7, p. e510, doi. 10.1634/theoncologist.2018-0501
- By:
- Publication type:
- Article
Monitoring and Management of Immune-Related Adverse Events Associated With Programmed Cell Death Protein-1 Axis Inhibitors in Lung Cancer.
- Published in:
- Oncologist, 2017, v. 22, n. 1, p. 70, doi. 10.1634/theoncologist.2016-0164
- By:
- Publication type:
- Article
Targeting the KRAS Pathway in Non-Small Cell Lung Cancer.
- Published in:
- Oncologist, 2016, v. 21, n. 12, p. 1450, doi. 10.1634/theoncologist.2015-0084
- By:
- Publication type:
- Article
Early Palliative Care and Its Role in Oncology: A Qualitative Study.
- Published in:
- Oncologist, 2016, v. 21, n. 11, p. 1387, doi. 10.1634/theoncologist.2016-0176
- By:
- Publication type:
- Article
The Value of Personalizing Medicine: Medical Oncologists' Views on Gene Expression Profiling in Breast Cancer Treatment.
- Published in:
- Oncologist, 2015, v. 20, n. 4, p. 351, doi. 10.1634/theoncologist.2014-0268
- By:
- Publication type:
- Article
Barriers and Challenges to Global Clinical Cancer Research.
- Published in:
- Oncologist, 2014, v. 19, n. 1, p. 61, doi. 10.1634/theoncologist.2013-0290
- By:
- Publication type:
- Article
Impact of New Chemotherapeutic and Targeted Agents on Survival in Stage IV Non-Small Cell Lung Cancer.
- Published in:
- Oncologist, 2011, v. 16, n. 9, p. 1307, doi. 10.1634/theoncologist.2011-0079
- By:
- Publication type:
- Article
A Phase II Study of Pazopanib in Patients with Recurrent or Metastatic Invasive Breast Carcinoma: A Trial of the Princess Margaret Hospital Phase II Consortium.
- Published in:
- Oncologist, 2010, v. 15, n. 8, p. 810, doi. 10.1634/theoncologist.2010-0081
- By:
- Publication type:
- Article